Concentric Capital Strategies’s Boston Scientific BSX Stock Holding History

Concentric Capital Strategies’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40,448	Closed	-$4.08M	–	281
2025 Q1	$4.08M	Buy	+40,448	New	+$4.07M	0.38%	47
2024 Q4	–	Sell	-96,363	Closed	-$8.08M	–	270
2024 Q3	$8.08M	Buy	96,363 +53,993	+127%	+$4.26M	0.33%	74
2024 Q2	$3.26M	Buy	42,370 +10,058	+31%	+$736K	0.16%	148
2024 Q1	$2.21M	Sell	32,312 -19,421	-38%	-$1.25M	0.12%	181
2023 Q4	$2.99M	Buy	+51,733	New	+$2.76M	0.34%	80
2022 Q4	–	Sell	-58,112	Closed	-$2.25M	–	149
2022 Q3	$2.25M	Buy	+58,112	New	+$2.33M	0.79%	47

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Concentric Capital Strategies's BSX Position: Q2 2025 in Review

Concentric Capital Strategies sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 40,448 shares — an estimated $4.08M sold.

Concentric Capital Strategies first reported a position in BSX in Q3 2022 and held it in 6 quarters. The position peaked at $8.08M in Q3 2024. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

Concentric Capital Strategies reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
Concentric Capital Strategies sold 40,448 Boston Scientific shares in Q2 2025, an estimated $4.08M.
Concentric Capital Strategies first reported a position in Boston Scientific in Q3 2022 and held it in 6 quarters.
Concentric Capital Strategies's Boston Scientific position peaked at $8.08M in Q3 2024.
1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Concentric Capital Strategies's 13F filing for Q2 2025, filed 15 Aug 2025.